TRIPODI FARIDA

Lambiase, A., Spandri, G., Moukham, H., Toini, E., D’Urzo, A., Zecca, G., et al. (2026). Acteoside exerts neuroprotective effects by preventing α-synuclein aggregation and oxidative stress in models of Parkinson's disease. NEUROTHERAPEUTICS, 23(1) [10.1016/j.neurot.2025.e00825]. Detail

Moukham, H., Caligaris, M., Six, P., Padovani, F., Schmoller, K., De Virgilio, C., et al. (2026). SNF1/AMPK controls its own localization by phosphorylating its activating kinase Sak1. ISCIENCE, 29(7), 1-13 [10.1016/j.isci.2026.116357]. Detail

Moukham, H., Spandri, G., Lambiase, A., Serio, S., Santoro, V., Piccinelli, A., et al. (2025). Targeting NAFLD via AMPK activation and Lipid droplet clearance: The Role of natural bioactive compounds. Intervento presentato a: SIB "Nutrition and Environment" and "Membrane", Bologna, Italia. Detail

Moukham, H., Galli, F., Spandri, G., Lambiase, A., Serio, S., Santoro, V., et al. (2025). Glabranin as a natural modulator of AMPK signaling and lipid metabolism in non-alcoholic fatty liver disease. Intervento presentato a: Forum Nazionale della Biodiversità 2025, Milano, Italia. Detail

Secchi, V., Armanni, A., Barbieri, L., Bruno, A., Colombo, A., Fumagalli, S., et al. (2025). Advanced techniques and nanotechnologies for point-of-care testing. FRONTIERS IN NANOTECHNOLOGY, 6 [10.3389/fnano.2024.1465429]. Detail